PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy

[Image: see text] INTRODUCTION: Drug repurposing is an effective strategy for identifying the use of approved drugs for new therapeutic purposes. This strategy has received particular attention in the development of cancer chemotherapy. Considering that a growing body of evidence suggesting the chol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefnezhad, Mina, Davaran, Soodabeh, Babazadeh, Mirzaagha, Akbarzadeh, Abolfazl, Pazoki-Toroudi, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329752/
https://www.ncbi.nlm.nih.gov/pubmed/37431480
http://dx.doi.org/10.34172/bi.2023.24252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329752/
https://www.ncbi.nlm.nih.gov/pubmed/37431480
http://dx.doi.org/10.34172/bi.2023.24252

Ejemplares similares